EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Targeted proteomics reveals novel biomarkers of disease activity and inflammation in acromegaly

Kristin Godang, Maren Ileby Wessel iD, Yusuf Khan, Thor Ueland iD, Tove Lekva, Jens Petter Berg, Jens Bollerslev iD, Nicoleta Cristina Olarescu iD

European Journal of Endocrinology · 30.04.2026 · 194 (5) · 732-743

DOI: 10.1093/ejendo/lvag083 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Endocrinology, online erschienen am 12.05.2026. Verfasst von Kristin Godang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Section of Specialized Endocrinology, Department of Endocrinology, Oslo University Hospital, 0372 Oslo, Norway. Hauptthemen laut MEDLINE: Acromegaly, Proteomics, Inflammation. Die Arbeit nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Norwegian Institute of Biomedical Science, Fondsstiftelsen, Oslo University Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Biochemical diagnostic approach for acromegaly relies heavily on the 2 biomarkers, growth hormone (GH) and insulin like growth factor 1 (IGF1), known to be dynamically affected, and influencing diagnostic accuracy. We sought to identify disease-specific biomarkers to improve diagnostic and disease activity monitoring and add insight into systemic effects of chronic GH/IGF1 excess.

Methods

Thirty-seven patients diagnosed with acromegaly were enrolled. A sub-cohort (n = 14) of these received primary somatostatin receptor ligand (SRL) treatment before surgery. Plasma samples collected at baseline, preoperative medical treatment and postoperative visits, were used to perform proteomic analysis of 184 proteins, with Olink Target 96 Cardiovascular III and Inflammation panels. Eight proteins were validated Enzyme Immunoassay (EIA). Dual-energy X-ray absorptiometry and biochemical measurements were performed at all visits.

Results

A total of 37 proteins were significantly differentially expressed (P-adjusted < .05) before and after disease control by surgery. Several proteins correlated with GH and IGF1. Interestingly, a strong correlation between some proteins and lean body mass, but not total adipose tissue, was observed. Strong correlation was observed between Olink and EIA measured protein levels. Enrichment analyses revealed 5 clusters, with extracellular matrix (ECM) remodeling and inflammation being most prominent. In addition, 5 proteins showed a temporal change with SRL treatment.

Conclusions

Acromegaly is associated with changes in ECM remodeling and inflammation. Several proteins were linked to disease activity, with glial cell derived neurotrophic factor and insulin like growth factor binding protein 2 serving as promising plasma biomarkers with potential to further optimize management of disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AcromegalyProteomicsInflammationHumansFemaleBiomarkersMaleMiddle AgedAdultInsulin-Like Growth Factor IHuman Growth HormoneAged

Stichwörter der Autor:innen

adipose tissuebody compositiondual-energy X-ray absorptiometrygrowth hormoneinsulin like growth factor 1muscle massproteomic Olink analysissomatostatin receptor ligand

Substanzen

BiomarkersInsulin-Like Growth Factor IHuman Growth HormoneIGF1 protein, human

Autor:innen und Institutionen

  • Section of Specialized Endocrinology, Department of Endocrinology, Oslo University Hospital, 0372 Oslo, Norway.
  • Faculty of Medicine, University of Oslo, 0372 Oslo, Norway.
  • Research Institute of Internal Medicine, Oslo University Hospital, 0372 Oslo, Norway.
  • Department of Cardiothoracic and Vascular Surgery, University Hospital of North Norway, 9019 Tromsø, Norway.
  • Department of Medical Biochemistry, Oslo University Hospital, 0450 Oslo, Norway.

ORCID-Profile: Maren Ileby Wessel, Thor Ueland, Jens Bollerslev, Nicoleta Cristina Olarescu

Förderung

  • Norwegian Institute of Biomedical Science
  • Fondsstiftelsen
  • Oslo University Hospital

Zitieren

APA

Godang, K., Wessel, M. I., Khan, Y., Ueland, T., Lekva, T., Berg, J. P., Bollerslev, J., & Olarescu, N. C. (2026). Targeted proteomics reveals novel biomarkers of disease activity and inflammation in acromegaly. European Journal of Endocrinology, 194(5), 732-743. https://doi.org/10.1093/ejendo/lvag083

Vancouver

Godang K, Wessel MI, Khan Y, Ueland T, Lekva T, Berg JP, et al. Targeted proteomics reveals novel biomarkers of disease activity and inflammation in acromegaly. European Journal of Endocrinology. 2026;194(5):732-743. doi:10.1093/ejendo/lvag083

BibTeX
@article{Godang2026,
  author = {Godang, Kristin and Wessel, Maren Ileby and Khan, Yusuf and Ueland, Thor and Lekva, Tove and Berg, Jens Petter and Bollerslev, Jens and Olarescu, Nicoleta Cristina},
  title = {Targeted proteomics reveals novel biomarkers of disease activity and inflammation in acromegaly},
  journal = {European Journal of Endocrinology},
  year = {2026},
  volume = {194},
  number = {5},
  pages = {732--743},
  doi = {10.1093/ejendo/lvag083}
}
Kostenlos starten →